Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacology and immuno-virologic efficacy of once-a-day HAART in African HIV-infected children: ANRS 12103 phase II trial.
Nacro B, Zoure E, Hien H, Tamboura H, Rouet F, Ouiminga A, Drabo A, Yameogo S, Hien A, Peyriere H, Mathieu O, Hirt D, Treluyer JM, Nicolas J, Foulongne V, Segondy M, van de Perre P, Diagbouga S, Msellati P. Nacro B, et al. Among authors: diagbouga s. Bull World Health Organ. 2011 Jun 1;89(6):451-8. doi: 10.2471/BLT.10.081646. Epub 2011 Apr 6. Bull World Health Organ. 2011. PMID: 21673861 Free PMC article. Clinical Trial.
Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname.
Barro M, Some J, Foulongne V, Diasso Y, Zouré E, Hien H, François R, Michel S, Drabo A, Tamboura H, Ouiminga A, Diagbouga S, Hien A, Yaméogo S, Van De Perre P, Nacro B, Msellati P. Barro M, et al. Among authors: diagbouga s. J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S44-9. doi: 10.1097/QAI.0b013e31821fd64f. J Acquir Immune Defic Syndr. 2011. PMID: 21857286 Clinical Trial.
Low prevalence rate of indeterminate serological human immunodeficiency virus results among pregnant women from Burkina Faso, West Africa.
Kania D, Fao P, Valéa D, Gouem C, Kagoné T, Hien H, Somda P, Ouédraogo P, Drabo A, Gampini S, Méda N, Diagbouga S, Van de Perre P, Rouet F; WHO/ANRS 1289 Kesho Bora Study Group in Burkina Faso. Kania D, et al. Among authors: diagbouga s. J Clin Microbiol. 2010 Apr;48(4):1333-6. doi: 10.1128/JCM.01734-09. Epub 2010 Feb 3. J Clin Microbiol. 2010. PMID: 20129958 Free PMC article.
CD4 count and CD4% in African HIV-infected people.
Anglaret X, Sylla-Koko F, Diagbouga S, Combe P, Van De Perre P, Dabis F. Anglaret X, et al. Among authors: diagbouga s. Int J Epidemiol. 1998 Oct;27(5):928-9. doi: 10.1093/ije/27.5.928. Int J Epidemiol. 1998. PMID: 9839756 No abstract available.
CD4+ T-lymphocyte counts in HIV infection: are European standards applicable to African patients?
Anglaret X, Diagbouga S, Mortier E, Meda N, Vergé-Valette V, Sylla-Koko F, Cousens S, Laruche G, Ledru E, Bonard D, Dabis F, Van de Perre P. Anglaret X, et al. Among authors: diagbouga s. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Apr 1;14(4):361-7. doi: 10.1097/00042560-199704010-00009. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9111479
24-Month adherence, tolerance and efficacy of once-a-day antiretroviral therapy with didanosine, lamivudine, and efavirenz in African HIV-1 infected children: ANRS 12103/12167.
Hien H, Meda N, Diagbouga S, Zoure E, Yaméogo S, Tamboura H, Somé J, Ouiminga A, Rouet F, Drabo A, Hien A, Nicolas J, Chappuy H, Van de Perre P, Msellati P, Nacro B. Hien H, et al. Among authors: diagbouga s. Afr Health Sci. 2013 Jun;13(2):287-94. doi: 10.4314/ahs.v13i2.13. Afr Health Sci. 2013. PMID: 24235926 Free PMC article. Clinical Trial.
55 results